Evrenzo (roxadustat) - Kyntra Bio
HIF-PH Inhibitor Promotes Stabilization of HIF-1α via Inhibition of Its Degradation and Exerts Chondroprotective Effects in a Rat Osteoarthritis Model. (PubMed, Int J Mol Sci) - Sep 16, 2026 - "These findings demonstrate that Roxadustat promotes anabolic responses in chondrocytes through stabilization of HIF-1α and suppresses cartilage degeneration in OA. Intra-articular administration of HIF-PH inhibitors may represent a novel disease-modifying therapeutic strategy for OA." 
Journal • Preclinical • Hematological Disorders • Immunology • Osteoarthritis • Pain • Rheumatology • ACAN • HIF1A • SOX9 • YBX1
http://www.ncbi.nlm.nih.gov/pubmed/42737766
 
Atsuo Inoue; Kei Nakamura; Keisuke Sugie; Kenji Takahashi; Kentaro Hayashi; Osam Mazda; Ryota Cha; Shuji Nakagawa; Tomoki Saito; Tsunao Kishida; Yuji Arai; Yuta Fujii
 
Sep 16, 2026
 
Prev Next